ZHZuzana Holubova

Zuzana Holubova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zuzana Holubova has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Electroclinical characteristics, genetic findings, and complex epilepsy surgery outcomes in children with low‐grade epilepsy‐associated tumors: A comprehensive view

    by Gonzalo Alonso Ramos Rivera, Barbora Straka, Petr Jezdík, Alice Maulisová, KateřIna Bukačová, Martin Kudr, Alena Jahodová, Aněžka Bělohlavková, Martin Kynčl, Zuzana Holubová, et al.

    Objective: To evaluate outcomes in relation to epilepsy characteristics and genetic findings in pediatric patients with isolated low‐grade epilepsy‐associated tumors (LEAT) and LEAT plus focal cortical dysplasia type IIIb (FCD IIIb) who underwent epilepsy surgery. Methods: Patients younger than 19 years at the time of surgery, with isolated LEAT or LEAT plus FCD IIIb, and a minimum follow‐up of 2 years were included. Clinical, neuroimaging, EEG, neuropsychological, surgical, histopathological, and molecular‐genetic data were analyzed. Outcomes and potential predictors were assessed across four domains: seizures, antiseizure medication (ASM) use, cognition (Full Scale Intelligence Quotient, FS‐IQ), and postoperative surgical complications. Results: Seventy‐one children fulfilled the inclusion criteria. Fifty‐one (71.8%) had drug‐resistant epilepsy. LEAT plus FCD IIIb were more frequent (43/71, 60.6%) than isolated LEAT (28/71, 39.4%). Gangliogliomas were the most common tumor type (39/71, 54.9%), followed by dysembryoplastic neuroepithelial tumors (16/71, 22.5%). Genetic testing demonstrated internal tandem duplication of the FGFR1 gene in most isolated LEAT cases (OR 11.9, 95% CI 1.32–100, p = .02), while LEAT+FCD IIIb cases were more frequently negative (OR 3.8, 95% CI 1.3–10.9, p = .02). After a median 5.7‐year follow‐up, 64 patients (90.1%) were seizure‐free, and 55 (77.5%) discontinued ASM. Earlier seizure onset, longer epilepsy duration, and a higher number of ASM correlated with lower pre‐ and postoperative FS‐IQ. A postoperative FS‐IQ gain of >15 points occurred in four patients (7.7%). Two patients (2.8%) had unexpected permanent deficits, and 10 (14.1%) had minor temporary deficits. Significance: Epilepsy surgery leads to high rates of freedom from seizures and ASM in pediatric patients with LEAT and LEAT + FCD IIIb. Early surgical intervention can be associated with higher pre‐ and postoperative FS‐IQ. Molecular‐genetic findings suggest distinct neoplastic and dysplastic entities of LEAT and LEAT plus FCD IIIb.

  • Open Access

    Abnormalities of thalamus and thalamocortical pathways in patients with refractory epilepsy caused by focal cortical dysplasia – MRI study

    by David Kala, Yeva Prysiazhniuk, Lukáš Michal, Jan Šanda, Zuzana Holubová, Martin Kudr, David Krýsl, Alice Maulisová, Kateřina Jiránková, Petr Marusič, et al.

    Objective: Drug‐resistant epilepsy, a severe and diagnostically challenging neurological condition often linked to focal cortical dysplasia (FCD), represents a significant social and healthcare burden. While the thalamus is notably altered in this disorder, it remains unclear whether these changes result from epilepsy manifestation or participate in its pathophysiology. This study aimed to characterize volumetric and microstructural changes in the thalamus and thalamocortical pathways in epilepsy patients with FCD. Methods: We prospectively enrolled 24 patients with drug‐resistant epilepsy caused by FCD and 16 age‐matched healthy controls. Diffusion MRI data and quantitative T1 were acquired, and advanced diffusion techniques – Diffusion Kurtosis Imaging (DKI), Neurite Orientation Dispersion and Density Imaging (NODDI), and Fixel‐Based Analysis (FBA) – were employed. Results: Volumetric analysis revealed a significant reduction in thalamic volume ipsilateral to the epileptic lesion. Microstructural analysis identified bilateral alterations in thalamocortical tracts, including changes in both DKI and NODDI diffusion metrics, indicating tissue disorganization and axonal integrity loss. However, no significant microstructural differences were observed between ipsilateral and contralateral thalami, suggesting that thalamic changes may be a consequence of epilepsy rather than its cause. Significance: This study investigates widespread structural and microstructural disruptions in the thalamus and thalamocortical networks in drug‐resistant epilepsy due to FCD, providing valuable insights into its complex pathophysiology and laying the groundwork for future research utilizing advanced diffusion imaging and analysis techniques. Plain Language Summary: This study used advanced MRI techniques to examine the thalamus ‐ a deep brain structure that relays signals and helps coordinate brain activity ‐ in people with focal epilepsy caused by abnormal development of the cerebral cortex, the part of the brain responsible for thinking, movement, and sensory processing, and where seizures often begin. Researchers found subtle structural changes in the thalamus and its connections to the cortex, even beyond the area directly affected by the lesion. These results provide new insight into how epilepsy can disrupt brain networks and offer a foundation for future studies using modern neuroimaging techniques.


  • Open Access

    ELECTROCLINICAL CHARACTERISTICS, GENETIC FINDINGS AND COMPLEX EPILEPSY SURGERY OUTCOMES IN CHILDREN WITH LOW-GRADE EPILEPSY-ASSOCIATED TUMORS – A COMPREHENSIVE VIEW

    by Gonzalo Alonso Rivera Ramos, Barbora Straka, Petr Jezdik, Alice Maulisova, Katerina Bukacova, Martin Kudr, Alena Jahodova, Anezka Belohlavkova, Martin Kyncl, Zuzana Holubova, et al.

    Objective To analyze postsurgical outcomes in relation to epilepsy characteristics and genetic etiology in pediatric patients with isolated low-grade epilepsy associated tumors (LEAT) and LEAT plus focal cortical dysplasia type IIIb (FCD IIIb) who underwent epilepsy surgery. Methods Patients younger than 19 years at the time of epilepsy surgery, with isolated LEAT or LEAT plus FCD IIIb and a minimum follow-up of 2 years were included. Clinical data, neuroimaging, EEG, neuropsychological findings, surgical variables, histopathological and molecular-genetic findings were evaluated. Surgical outcomes were assessed in four domains: seizures, antiseizure medication (ASM) use, cognitive performance changes and complications, including predictor analysis. Results Seventy-three children fulfilled the inclusion criteria, with 53 (72.6%) having drug-resistant epilepsy. LEAT plus FCD IIIb were more frequent than isolated LEAT (44/73, 60.3% vs. 29/73, 39.7%) and gangliogliomas were the most common tumor type (43/73, 58.9%), followed by dysembryoplastic neuroepithelial tumor (19/73, 26.0 %). Genetic testing was more frequently positive in isolated LEAT (20/28) than LEAT plus FCD IIIb (18/43, p = 0.02). At the end of follow-up (median 5.7 years), 66 patients (90.4%) were seizure-free, and 57 (78.1%) had discontinued ASM. Younger age at seizure onset, longer epilepsy duration, and a higher number of ASM were correlated to lower pre- and postoperative IQ. An IQ gain of > 10 pts. postoperatively was present in 8 patients (15.1%). Two patients (2.7%) had an unexpected permanent deficit, while 10 (13.7%) had minor temporary deficit. No additional predictive outcome factors were identified. Significance Epilepsy surgery yields high chances of freedom from seizures and ASM discontinuation. Early surgical intervention in terms of shorter duration of epilepsy and fewer used ASM can be associated to a higher pre- and postoperative IQ. Molecular-genetic differences between isolated LEAT and LEAT plus FCD IIIb suggest distinct neoplastic and dysplastic entities, respectively. Key points A majority of patients with LEAT achieved freedom from seizures and ASM post-surgically. Children with younger age at seizure onset, longer duration of epilepsy and a higher number of ASM used before surgery had lower pre- and postoperative IQ. Genetic cause was detected more often in patients with isolated LEAT vs. LEAT + FCD IIIb implying their neoplastic respectively dysplastic origin.

  • Open Access

    A new perspective on drug‐resistant epilepsy in children with focal cortical dysplasia type 1: From challenge to favorable outcome

    by Barbora Splitkova, Katerina Mackova, Miroslav Koblizek, Zuzana Holubova, Martin Kyncl, Katerina Bukacova, Alice Maulisova, Barbora Straka, Martin Kudr, Matyas Ebel, et al.

    Objective: We comprehensively characterized a large pediatric cohort with focal cortical dysplasia (FCD) type 1 to expand the phenotypic spectrum and to identify predictors of postsurgical outcomes. Methods: We included pediatric patients with histopathological diagnosis of isolated FCD type 1 and at least 1 year of postsurgical follow‐up. We systematically reanalyzed clinical, electrophysiological, and radiological features. The results of this reanalysis served as independent variables for subsequent statistical analyses of outcome predictors. Results: All children ( N = 31) had drug‐resistant epilepsy with varying impacts on neurodevelopment and cognition (presurgical intelligence quotient [IQ]/developmental quotient scores = 32–106). Low presurgical IQ was associated with abnormal slow background electroencephalographic (EEG) activity and disrupted sleep architecture. Scalp EEG showed predominantly multiregional and often bilateral epileptiform activity. Advanced epilepsy magnetic resonance imaging (MRI) protocols identified FCD‐specific features in 74.2% of patients (23/31), 17 of whom were initially evaluated as MRI‐negative. In six of eight MRI‐negative cases, fluorodeoxyglucose–positron emission tomography (PET) and subtraction ictal single photon emission computed tomography coregistered to MRI helped localize the dysplastic cortex. Sixteen patients (51.6%) underwent invasive EEG. By the last follow‐up (median = 5 years, interquartile range = 3.3–9 years), seizure freedom was achieved in 71% of patients (22/31), including seven of eight MRI‐negative patients. Antiseizure medications were reduced in 21 patients, with complete withdrawal in six. Seizure outcome was predicted by a combination of the following descriptors: age at epilepsy onset, epilepsy duration, long‐term invasive EEG, and specific MRI and PET findings. Significance: This study highlights the broad phenotypic spectrum of FCD type 1, which spans far beyond the narrow descriptions of previous studies. The applied multilayered presurgical approach helped localize the epileptogenic zone in many previously nonlesional cases, resulting in improved postsurgical seizure outcomes, which are more favorable than previously reported for FCD type 1 patients.


  • Open Access

    Multi-layered Diagnostic Protocol Improves Postsurgical Outcomes in Children with Drug-resistant Epilepsy And Focal Cortical Dysplasia Type 1

    by Barbora Splitkova, Katerina Mackova, Miroslav Koblizek, Zuzana Holubova, Martin Kyncl, Katerina Bukacova, Alice Maulisova, Barbora Straka, Martin Kudr, Matyas Ebel, et al.

    Objectives: We comprehensively characterised a large paediatric cohort with histologically confirmed focal cortical dysplasia (FCD) type 1 to demonstrate the role of advanced multimodal pre-surgical evaluation and identify predictors of postsurgical outcomes. Methods: This study comprised a systematic re-analysis of clinical, electrophysiological, and radiological features. The results of this re-analysis served as independent variables for subsequent statistical analyses of outcome predictors. Results: All children (N = 31) had drug-resistant epilepsy with varying impacts on neurodevelopment and cognition (presurgical intelligence quotient (IQ)/developmental quotient scores: 32–106). Low presurgical IQ was associated with abnormal slow background electroencephalogram (EEG) activity and disrupted sleep architecture. Scalp EEG showed predominantly multiregional and often bilateral epileptiform activity. Advanced epilepsy magnetic resonance imaging (MRI) protocols identified FCD-specific features in 74.2% of patients (23/31), 17 of whom were initially evaluated as MRI-negative. In six out of eight MRI-negative cases, fluorodeoxyglucose positron emission tomography (FDG-PET) and subtraction ictal single-photon emission computed tomography co-registered to MRI (SISCOM) helped localise the dysplastic cortex. Sixteen patients (51.6%) underwent stereoelectroencephalography (SEEG). Twenty-eight underwent resective surgery, and three underwent hemispheral disconnection. Seizure freedom was achieved in 71.0% of patients (22/31) by the last follow-up, including seven of the eight MRI-negative patients. Anti-seizure medications (ASMs) were reduced in 21 patients, with complete withdrawal in 5 individuals. Seizure outcome was predicted by a combination of the following descriptors: age at epilepsy onset, epilepsy duration, long-term invasive EEG, and specific MRI, and PET findings. Significance: This study highlights the broad phenotypic spectrum of FCD type 1, which spans far beyond the narrow descriptions of previous studies. Combining advanced MRI protocols with additional neuroimaging techniques helped localise the epileptogenic zone in many previously non-lesional cases. Complex multimodal presurgical approaches (including SEEG) could enhance postsurgical outcomes in these complex patients. Key points: The phenotypic spectrum of paediatric patients with FCD type 1 spans beyond the narrow description of previous studies MRI-negative patients benefit from enhanced precision in localising the epileptogenic zone, facilitated by FDG-PET, SISCOM, and SEEG A complex multimodal presurgical approach could enhance postoperative seizure outcomes in patients with FCD type 1 Paediatric patients with suspected FCD type 1 should be referred to epilepsy surgery centres as soon as possible